5 Oct 2026, 08:22
Company UpdateMS
CSLCSL LIMITED
Announcement history available from 1 August 2025
Fromto
24 Sept 2026, 08:22
Buybacks & Capital Management—
23 Sept 2026, 08:17
Buybacks & Capital Management—
22 Sept 2026, 08:22
Buybacks & Capital Management—
18 Sept 2026, 08:21
Buybacks & Capital Management—
17 Sept 2026, 08:21
Buybacks & Capital Management—
17 Sept 2026, 08:19
Meetings & Governance—
16 Sept 2026, 08:24
Buybacks & Capital Management—
15 Sept 2026, 08:21
Buybacks & Capital Management—
14 Sept 2026, 08:22
Dividends & Distributions—
8 Sept 2026, 16:31
Buybacks & Capital Management—
8 Sept 2026, 16:30
Securities Administration—
8 Sept 2026, 16:26
Securities Administration—
7 Sept 2026, 16:42
Securities Administration—
4 Sept 2026, 08:20
Securities Administration—
4 Sept 2026, 08:20
Securities Administration—
4 Sept 2026, 08:14
Substantial Holders—
3 Sept 2026, 17:03
Director Interests—
3 Sept 2026, 16:47
Director Interests—
3 Sept 2026, 16:45
Director Interests—
3 Sept 2026, 16:44
Director Interests—
3 Sept 2026, 16:44
Director Interests—
3 Sept 2026, 16:43
Director Interests—
3 Sept 2026, 16:41
Director Interests—
3 Sept 2026, 16:40
Director Interests—
3 Sept 2026, 16:39
Director Interests—
3 Sept 2026, 16:38
Securities Administration—
1 Sept 2026, 08:17
Company Update—
27 Aug 2026, 17:05
Director Interests—
27 Aug 2026, 17:04
Director Interests—
27 Aug 2026, 17:03
Director Interests—
27 Aug 2026, 17:02
Director Interests—
27 Aug 2026, 17:01
Director Interests—
27 Aug 2026, 17:00
Director Interests—
27 Aug 2026, 16:58
Director Interests—
27 Aug 2026, 16:53
Securities Administration—
26 Aug 2026, 16:53
Buybacks & Capital Management—
18 Aug 2026, 08:02
Company Administration—
18 Aug 2026, 08:01
Financial ResultsMS
18 Aug 2026, 08:00
Dividends & Distributions—
18 Aug 2026, 08:00
Financial ResultsMS
18 Aug 2026, 07:58
Financial ResultsMS
6 Aug 2026, 08:20
Securities Administration—
5 Aug 2026, 08:23
Periodic Reports—
29 July 2026, 09:21
Company UpdateMS
7 July 2026, 16:31
Securities Administration—
29 June 2026, 09:31
Company Update—
9 June 2026, 16:33
Securities Administration—
5 June 2026, 08:23
Director Interests—
3 June 2026, 08:53
Substantial Holders—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 5 Oct 2026, 08:22 | CSL enters exclusive agreement with Alentis Therapeutics | Company Update | MS | 11001 | |
| 24 Sept 2026, 08:22 | Update - Notification of buy-back - CSL | Buybacks & Capital Management | — | 06012 | |
| 23 Sept 2026, 08:17 | Update - Notification of buy-back - CSL | Buybacks & Capital Management | — | 06012 | |
| 22 Sept 2026, 08:22 | Update - Notification of buy-back - CSL | Buybacks & Capital Management | — | 06012 | |
| 18 Sept 2026, 08:21 | Update - Notification of buy-back - CSL | Buybacks & Capital Management | — | 06012 | |
| 17 Sept 2026, 08:21 | Update - Notification of buy-back - CSL | Buybacks & Capital Management | — | 06012 | |
| 17 Sept 2026, 08:19 | Notice of Meeting and Shareholder Pack 2026 | Meetings & Governance | — | 08001, 08004 | |
| 16 Sept 2026, 08:24 | Update - Notification of buy-back - CSL | Buybacks & Capital Management | — | 06012 | |
| 15 Sept 2026, 08:21 | Update - Notification of buy-back - CSL | Buybacks & Capital Management | — | 06012 | |
| 14 Sept 2026, 08:22 | Update - Dividend/Distribution - CSL | Dividends & Distributions | — | 10001, 10002, 10003 | |
| 8 Sept 2026, 16:31 | Update - Notification of buy-back - CSL | Buybacks & Capital Management | — | 06011 | |
| 8 Sept 2026, 16:30 | Application for quotation of securities - CSL | Securities Administration | — | 06020 | |
| 8 Sept 2026, 16:26 | Notification regarding unquoted securities - CSL | Securities Administration | — | 06021 | |
| 7 Sept 2026, 16:42 | Notification of cessation of securities - CSL | Securities Administration | — | 06027 | |
| 4 Sept 2026, 08:20 | Notification of cessation of securities - CSL | Securities Administration | — | 06027 | |
| 4 Sept 2026, 08:20 | Application for quotation of securities - CSL | Securities Administration | — | 06020 | |
| 4 Sept 2026, 08:14 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 3 Sept 2026, 17:03 | Appendix 3Y - Alison Watkins AM | Director Interests | — | 02009 | |
| 3 Sept 2026, 16:47 | Appendix 3Y - Elaine Sorg | Director Interests | — | 02009 | |
| 3 Sept 2026, 16:45 | Appendix 3Y - Costa Saroukos | Director Interests | — | 02009 | |
| 3 Sept 2026, 16:44 | Appendix 3Y - Cameron Price | Director Interests | — | 02009 | |
| 3 Sept 2026, 16:44 | Appendix 3Y - Samantha Lewis | Director Interests | — | 02009 | |
| 3 Sept 2026, 16:43 | Appendix 3Y - Carolyn Hewson AO | Director Interests | — | 02009 | |
| 3 Sept 2026, 16:41 | Appendix 3Y - Brian Daniels | Director Interests | — | 02009 | |
| 3 Sept 2026, 16:40 | Appendix 3Y - Andrew Cuthbertson AO | Director Interests | — | 02009 | |
| 3 Sept 2026, 16:39 | Appendix 3Y - Brian McNamee AO | Director Interests | — | 02009 | |
| 3 Sept 2026, 16:38 | Notification regarding unquoted securities - CSL | Securities Administration | — | 06021 | |
| 1 Sept 2026, 08:17 | Agreements with U.S. on Drug Prices and Manufacturing | Company Update | — | 11001 | |
| 27 Aug 2026, 17:05 | Appendix 3Y - Alison Watkins AM | Director Interests | — | 02009 | |
| 27 Aug 2026, 17:04 | Appendix 3Y - Costa Saroukos | Director Interests | — | 02009 | |
| 27 Aug 2026, 17:03 | Appendix 3Y - Cameron Price | Director Interests | — | 02009 | |
| 27 Aug 2026, 17:02 | Appendix 3Y - Samantha Lewis | Director Interests | — | 02009 | |
| 27 Aug 2026, 17:01 | Appendix 3Y - Carolyn Hewson AO | Director Interests | — | 02009 | |
| 27 Aug 2026, 17:00 | Appendix 3Y - Andrew Cuthbertson AO | Director Interests | — | 02009 | |
| 27 Aug 2026, 16:58 | Appendix 3Y - Brian McNamee AO | Director Interests | — | 02009 | |
| 27 Aug 2026, 16:53 | Notification regarding unquoted securities - CSL | Securities Administration | — | 06021 | |
| 26 Aug 2026, 16:53 | Notification of buy-back - CSL | Buybacks & Capital Management | — | 06011 | |
| 18 Aug 2026, 08:02 | CSL Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 18 Aug 2026, 08:01 | CSL Results Presentation for FY2026 | Financial Results | MS | 03003, 03026 | |
| 18 Aug 2026, 08:00 | Dividend/Distribution - CSL | Dividends & Distributions | — | 10001, 10002, 10003 | |
| 18 Aug 2026, 08:00 | CSL FY2026 Results | Financial Results | MS | 03003, 10003, 14014 | |
| 18 Aug 2026, 07:58 | CSL Statutory Accounts for FY2026 | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020, 03029, 08006, 10001, 10002, 10003 | |
| 6 Aug 2026, 08:20 | Notification of cessation of securities - CSL | Securities Administration | — | 06027 | |
| 5 Aug 2026, 08:23 | Notice of Investor/Analyst Briefing 2026 Full Year Result | Periodic Reports | — | 03027 | |
| 29 July 2026, 09:21 | CSL Update on Enhanced Plasma Manufacturing | Company Update | MS | 11001 | |
| 7 July 2026, 16:31 | Notification of cessation of securities - CSL | Securities Administration | — | 06027 | |
| 29 June 2026, 09:31 | Update on TAVNEOS | Company Update | — | 11001 | |
| 9 June 2026, 16:33 | Notification of cessation of securities - CSL | Securities Administration | — | 06027 | |
| 5 June 2026, 08:23 | Appendix 3Y - Carolyn Hewson AO | Director Interests | — | 02009 | |
| 3 June 2026, 08:53 | Change in substantial holding | Substantial Holders | — | 02002 |
1–50 of 212
1 / 5